Sales, Capital Raise and Meetings
Rua Rau Hiwa is sourced under New Zealand's unique regulatory framework, which permits the inclusion of legacy genetics in the medicinal cannabis sector, Rau Hiwa T23 pays homage to the safekeepers of distinctive cannabis genetics in our community and Aotearoa, New Zealand.
Rua Half-Year Result – Constructive Period with First Product, First Revenue Imminent
Rua Half-Year Result – Constructive Period with First Product, First Revenue Imminent. Rua Bioscience Limited (NZX: RUA) has today announced its financial results for the six months to 31 December 2021.
The loss after tax for the six months to 31 December 2021 was $2.46m, with total cash and investments on hand at the end of the period of $12.29m.